Agenzia Italiana del Farmaco
Spikevax - Vaccine Moderna mRNA-1273
Spikevax (ex COVID-19 Moderna mRNA -1273) is a vaccine intended to prevent coronavirus disease 2019 (COVID-19) in people six months of age and over.
This is the second COVID-19 vaccine authorised by AIFA in Italy (January 7, 2021), after the Comirnaty vaccine. It contains a molecule called messenger RNA (mRNA) with instructions for producing a protein found on SARS-CoV-2, the virus responsible for COVID-19.